The measure appears to target the EU, the main supplier of patented medicines to the US

US President Donald Trump has announced a 100% tariff on imports of branded drugs starting from October, in a move aimed at forcing manufacturers to shift production to America.

Trump has overhauled US trade policy since returning to office, imposing sweeping tariffs on key trading partners to protect domestic industry. The US president has long argued that tariffs fix unfair trade deficits and stop other countries from “ripping off” the US. Critics say the policy raises domestic prices and hurts the economy.

The new drug tariff will not apply to companies…

Read the full article at RT.COM